Oxford Biomedica plc (LON:OXB - Get Free Report) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 391.49 ($4.93) and traded as high as GBX 403 ($5.07). Oxford Biomedica shares last traded at GBX 391 ($4.92), with a volume of 201,486 shares trading hands.
Oxford Biomedica Price Performance
The company has a debt-to-equity ratio of 166.48, a quick ratio of 1.67 and a current ratio of 2.35. The company's fifty day simple moving average is GBX 414.78 and its two-hundred day simple moving average is GBX 392.27. The stock has a market capitalization of £414.57 million, a PE ratio of -2.90 and a beta of 1.09.
Oxford Biomedica Company Profile
(
Get Free Report)
Oxford Biomedica LSE: OXB is a quality and innovation-led cell and gene therapy CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world.
One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.
Recommended Stories
Before you consider Oxford Biomedica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford Biomedica wasn't on the list.
While Oxford Biomedica currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
